Better Buy: Johnson & Johnson vs. Merck

Better Buy: Johnson & Johnson vs. Merck

This big pharma claims one of the hottest cancer drugs around. But it also faces challenges for some of its biggest-selling drugs. Which big pharma is it?

Actually, it's two: Johnson & Johnson (NYSE: JNJ) and Merck (NYSE: MRK). 

These companies are similar in several ways. However, Johnson & Johnson stock is up big in 2017, while Merck stock has lost ground this year. Will J&J continue to be the better pick, or will Merck roar back? Here's how these pharma stocks compare.

Continue reading

Source: Fool.com